# A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion

> **NCT00626600** · PHASE3 · TERMINATED · sponsor: **Mundipharma Research Limited** · enrollment: 33 (actual)

## Conditions studied

- Severe Caner Pain

## Interventions

- **DRUG:** Oxycodone Hydrochloride

## Key facts

- **NCT ID:** NCT00626600
- **Lead sponsor:** Mundipharma Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2009-05
- **Final completion:** 2009-06
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2018-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626600, "A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00626600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*